Sun Pharma began in 1983 with five products and now sells in over 100 countries
In short: Sun Pharmaceutical Industries started in Calcutta in 1983 with a handful of psychiatry drugs and a very small sales force. Today it is India's largest pharmaceutical company and sells in more than 100 countries. Much of its growth came from buying other firms, some of them very large. Its history shows how a small drugmaker can grow into an international player.
Sun Pharmaceutical Industries Limited, known as Sun Pharma, is headquartered in Mumbai. It makes pharmaceutical formulations and active pharmaceutical ingredients, selling them in more than 100 countries. Its manufacturing spans 43 locations across India, the United States, Asia, Africa, Australia and Europe. The company was founded by Dilip Shanghvi in 1983 in Calcutta, West Bengal. Its early range was small, centred on psychiatry. A major step toward the international market came in 1997, when it acquired Caraco Pharmaceuticals, based in Detroit, its first overseas acquisition.
Growth through acquisition continued over the following years. In 2010 Sun gained a controlling stake in Taro Pharmaceuticals, which is counted among the largest generic dermatology companies in the United States. A much larger deal followed in 2014, when Sun announced a transaction worth US$4 billion to buy Ranbaxy Laboratories. The stated goal was to form the world's fifth-largest specialty generic company by sales. Acquisitions of this scale also invite regulatory review, and the Competition Commission of India, which approved the bid in December 2014, required the firms to divest seven products so that competition in the market was not harmed.
Today the business is weighted heavily abroad. Around 70% of its revenue comes from international markets, and the United States and India together account for more than 60% of turnover. Its therapy areas now cover psychiatry, neurology, cardiology, diabetology, oncology and several others. Sun's path shows how a company can widen its portfolio step by step, combining its own research with purchases of firms that bring new products, plants and customers. Its own research arm, Sun Pharma Advanced Research Company, was listed separately in 2007 and focuses on new chemical entities and drug delivery systems.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Sun Pharma
- Also: find-and-update.company-information.service.gov.uk — SUN PHARMA UK LIMITED overview - Find and update company information - GOV.UK
To cite this card, link to https://intellectplus.co.uk/app/wealth-sun-pharma.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Economic history · More in Wealth & Business · Latest · A–Z · All topics